FREE SHIPPING ON ORDERS OVER $150

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

$27.75

Quantity
- +
Description

Blueberry-raspberry: Acid (citric acid), acidity regulator (sodium carbonates), L-carnitine L-tartrate 12.5%, bulkingagent (sorbitol), flavours, colour (beetroot red powder), sweetener (sucralose)

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Goldman R., Moss J.X

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

NLT, not less than

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

Trial Registration University hospital Medical Information Network (UMIN) UMIN000003760 Citation: Miyagawa T, Kawamura H, Obuchi M, Ikesaki A, Ozaki A, Tokunaga K, et al

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

Bentez-Muoz, J

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

Can J Physiol Pharmacol

l-carnitine in management of valproic acid induced hyperammonemia Suggested Action 23 Hyperammonemic encephalopathy induced by valproic

You may also like

recommand products